{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:05:50Z","timestamp":1784955950449,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,26]]},"DOI":"10.7759\/cureus.81220","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T11:09:44Z","timestamp":1742987384000},"source":"Crossref","is-referenced-by-count":1,"title":["Chronic Myeloid Leukemia in a Young Adult"],"prefix":"10.7759","author":[{"given":"Kalan","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawhar","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Jagadish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata","family":"Vedantam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Daugherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25011","article-title":"Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring","volume":"93","author":"Jabbour E","year":"2018","unstructured":"Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring. Am J Hematol. 2018, 93:442-59. 10.1002\/ajh.25011","journal-title":"Am J Hematol"},{"key":"ref2","article-title":"WHO classification of tumors of hematopoietic and lymphoid tissue","author":"Swerdlow SH","year":"2017","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. WHO classification of tumors of hematopoietic and lymphoid tissue. International Agency for Research on Cancer (ed): World Health Organization, France; 2017."},{"key":"ref3","unstructured":"SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). (2012). Accessed. February 1, 2025: http:\/\/seer.cancer.gov\/csr\/1975_2009_pops09."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.245","article-title":"Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph\/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany","volume":"23","author":"Rohrbacher M","year":"2009","unstructured":"Rohrbacher M, Berger U, Hochhaus A, et al.. Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph\/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany. Leukemia. 2009, 23:602-4. 10.1038\/leu.2008.245","journal-title":"Leukemia"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V63.4.789.789","article-title":"Prognostic discrimination in \"good-risk\" chronic granulocytic leukemia","volume":"63","author":"Sokal JE","year":"1984","unstructured":"Sokal JE, Cox EB, Baccarani M, et al.. Prognostic discrimination in \"good-risk\" chronic granulocytic leukemia. Blood. 1984, 63:789-99. 10.1182\/blood.V63.4.789.789","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10239","article-title":"Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party","volume":"92","author":"Rosti G","year":"2007","unstructured":"Rosti G, Iacobucci I, Bassi S, et al.. Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party. Haematologica. 2007, 92:101-5. 10.3324\/haematol.10239","journal-title":"Haematologica"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-324228","article-title":"Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party","volume":"117","author":"Gugliotta G","year":"2011","unstructured":"Gugliotta G, Castagnetti F, Palandri F, et al.. Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party. Blood. 2011, 117:5591-9. 10.1182\/blood-2010-12-324228","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.056721","article-title":"Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy","volume":"97","author":"Pemmaraju N","year":"2012","unstructured":"Pemmaraju N, Kantarjian H, Shan J, et al.. Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy. Haematologica. 2012, 97:1029-35. 10.3324\/haematol.2011.056721","journal-title":"Haematologica"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2010.1.21","article-title":"Adolescents and young adults with acute lymphoblastic leukemia","volume":"2010","author":"Stock W","year":"2010","unstructured":"Stock W. Adolescents and young adults with acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program. 2010, 2010:21-9. 10.1182\/asheducation-2010.1.21","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2009.03.001","article-title":"Breast cancer before age 40 years","volume":"36","author":"Anders CK","year":"2009","unstructured":"Anders CK, Johnson R, Litton J, Phillips M, Bleyer A. Breast cancer before age 40 years. Semin Oncol. 2009, 36:237-49. 10.1053\/j.seminoncol.2009.03.001","journal-title":"Semin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200001133420216","article-title":"Genetic and phenotypic correlates of colorectal cancer in young patients","volume":"342","author":"Datta RV","year":"2000","unstructured":"Datta RV, LaQuaglia MP, Paty PB. Genetic and phenotypic correlates of colorectal cancer in young patients. N Engl J Med. 2000, 342:137-8. 10.1056\/NEJM200001133420216","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/01.mph.0000157790.81329.47","article-title":"Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature","volume":"27","author":"Prakash S","year":"2005","unstructured":"Prakash S, Sarran L, Socci N, et al.. Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature. J Pediatr Hematol Oncol. 2005, 27:179-87. 10.1097\/01.mph.0000157790.81329.47","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2349","article-title":"The distinctive biology of cancer in adolescents and young adults","volume":"8","author":"Bleyer A","year":"2008","unstructured":"Bleyer A, Barr R, Hayes-Lattin B, Thomas D, Ellis C, Anderson B. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer. 2008, 8:288-98. 10.1038\/nrc2349","journal-title":"Nat Rev Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.85","article-title":"Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)","volume":"26","author":"Hanfstein B","year":"2012","unstructured":"Hanfstein B, M\u00fcller MC, Hehlmann R, et al.. Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML). Leukemia. 2012, 26:2096-102. 10.1038\/leu.2012.85","journal-title":"Leukemia"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.6565","article-title":"Assessment of BCR-ABL1 transcript levels at 3 months is the only requirement for predicting outcome for patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors","volume":"30","author":"Marin D","year":"2012","unstructured":"Marin D, Ibrahim AR, Lucas C, et al.. Assessment of BCR-ABL1 transcript levels at 3 months is the only requirement for predicting outcome for patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. J Clin Oncol. 2012, 30:232-8. 10.1200\/JCO.2011.38.6565","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-501569","article-title":"European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013","volume":"122","author":"Baccarani M","year":"2013","unstructured":"Baccarani M, Deininger MW, Rosti G, et al.. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood. 2013, 122:872-84. 10.1182\/blood-2013-05-501569","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200001133420201","article-title":"Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer","volume":"342","author":"Gryfe R","year":"2000","unstructured":"Gryfe R, Kim H, Hsieh ET, et al.. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med. 2000, 342:69-77. 10.1056\/NEJM200001133420201","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25369","article-title":"Clinical and molecular features of papillary thyroid cancer in adolescents and young adults","volume":"117","author":"Vriens MR","year":"2011","unstructured":"Vriens MR, Moses W, Weng J, et al.. Clinical and molecular features of papillary thyroid cancer in adolescents and young adults. Cancer. 2011, 117:259-67. 10.1002\/cncr.25369","journal-title":"Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.19","article-title":"Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients","volume":"27","author":"Mustjoki S","year":"2013","unstructured":"Mustjoki S, Richter J, Barbany G, et al.. Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients. Leukemia. 2013, 27:1520-6. 10.1038\/leu.2013.19","journal-title":"Leukemia"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-013-1937-4","article-title":"Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV","volume":"93","author":"Kalmanti L","year":"2014","unstructured":"Kalmanti L, Saussele S, Lauseker M, et al.. Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV. Ann Hematol. 2014, 93:71-80. 10.1007\/s00277-013-1937-4","journal-title":"Ann Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/347354-chronic-myeloid-leukemia-in-a-young-adult","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T11:09:56Z","timestamp":1742987396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/347354-chronic-myeloid-leukemia-in-a-young-adult"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.81220","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,26]]}}}